CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lipella Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lipella Pharmaceuticals Inc
7800 Susquehanna St, Suite 505
Phone: (302) 777-0210p:302 777-0210 PITTSBURGH, PA  15208  United States Ticker: LIPOLIPO
Filed for Bankruptcy on 3/30/2026
Case #26-20879, filed in the U.S. Bankruptcy Court for the Western District Of Pennsylvania (Pittsburgh)
Business Summary
Lipella Pharmaceuticals Inc. was a clinical-stage biotechnology company. The Company is no longer in operation and does not have any business activities.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024YesYesYes--

Industries
SIC Code Description
2834 Pharmaceutical preparations
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary Jonathan H.Kaufman 59 1/1/2005 1/1/2005
Chief Financial Officer DouglasJohnston 40 11/9/2022 10/1/2021
Independent Director DanielCohen 60 3/21/2023 3/21/2023
Independent Director ByeongKim 54 3/1/2022 3/1/2022
Independent Director RyanPruchnic 50 9/1/2021 9/1/2021

General Information
Number of Employees: 5 (As of 3/26/2025)
Outstanding Shares: 4,620,837 (As of 11/13/2025)
Shareholders: 15
Stock Exchange: OTC
Federal Tax Id: 202388040
Fax Number: (302) 658-3694


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 25, 2026